abstract: Difficulties associated with long-term culture of primary trophoblasts have proven to be a major hurdle in their functional characterization. In order to circumvent this issue, several model cell lines have been established over many years using a variety of different approaches. Due to their differing origins, gene expression profiles and behaviour in vitro, different model lines have been utilized to investigate specific aspects of trophoblast biology. However, generally speaking, the molecular mechanisms underlying functional differences remain unclear. In this study, we profiled genome-scale DNA methylation in primary first trimester trophoblast cells and seven commonly used trophoblast-derived cell lines in an attempt to identify functional pathways differentially regulated by epigenetic modification in these cells. We identified a general increase in DNA promoter methylation levels in four choriocarcinoma (CCA)-derived lines and transformed HTR-8/SVneo cells, including hypermethylation of several genes regularly seen in human cancers, while other differences in methylation were noted in genes linked to immune responsiveness, cell morphology, development and migration across the different cell populations. Interestingly, CCA-derived lines show an overall methylation profile more similar to unrelated solid cancers than to untransformed trophoblasts, highlighting the role of aberrant DNA methylation in CCA development and/or long-term culturing. Comparison of DNA methylation and gene expression in CCA lines and cytotrophoblasts revealed a significant contribution of DNA methylation to overall expression profile. These data highlight the variability in epigenetic state between primary trophoblasts and cell models in pathways underpinning a wide range of cell functions, providing valuable candidate pathways for future functional investigation in different cell populations. This study also confirms the need for caution in the interpretation of data generated from manipulation of such pathways in vitro.
Introduction
The human placenta is a temporary extra-embryonic organ that facilitates the exchange of nutrients and waste between the mother and fetus (Gauster et al., 2009) . It is heterogeneous in nature, comprising several cell types including trophoblasts (derived from the trophectoderm), mesenchymal cells (extraembryonic and embryonic in origin), stromal fibroblasts and connective tissue, amongst others.
The trophoblast population is composed of three distinct cell types-stem-cell like villous cytotrophoblasts (CTBs), a multinucleated syncytiotrophoblast (ST) layer and invasive extravillous trophoblasts (EVTs) (Benerischke and Kaufmann, 2006) . Each of these has specialized functions, important for proper placental and † All Infinium HumanMethylation27 array data is available on the NCBI Gene Expression Omnibus, accession number: GSE26683. fetal development. Not surprisingly, cells of these different compartments display differences in morphology, function and antigen and gene expression (Huppertz, 2008) . Additionally, these populations differ in their expression of molecules involved in cell adhesion, proteases and their inhibitors, cytokines, chemokines, growth factors and receptors and human leucocyte antigen (HLA) molecules (reviewed in (Hannan et al., 2010) ). For example, CTBs do not express HLA-G, while EVTs express HLA-C, HLA-E and HLA-G, but not HLA-A and HLA-B or HLA-DR (Apps et al., 2009) .
A variety of approaches are available for isolating specific populations of primary trophoblast cells for functional characterization (Loke et al., 1989; Yeger et al., 1989; Caulfield et al., 1992 , AboagyeMathiesen et al., 1996 Manoussaka et al., 2005 , Petroff et al., 2006 , James et al., 2007 Stenqvist et al., 2008; Apps et al., 2009) . Generally speaking, these are labor intensive and the resulting cells are suitable for only short-term characterization of specific trophoblast function in vitro [discussed in (King et al., 2000) ]. Consequently trophoblastderived cell lines have become an important tool for studying processes underlying placental development and function.
Each of the widely used trophoblast-derived cell lines has its own unique origin, functional characteristics and antigenic properties (King et al., 2000; Frank et al., 2001; Shiverick et al., 2001; Sullivan, 2004; Apps et al., 2009; Hannan et al., 2010; Fig. 1) . In general terms, functions of the primary cells and tissues, from which they were derived, are at least partially replicated within cell lines, making them useful for dissecting mechanisms underlying specific trophoblast functions. Cell lines derived from gestational choriocarcinoma (CCA) were the first to be developed and have proven invaluable in studying trophoblast migration, as unlike many other tumour cells, some maintain their invasive potential in culture (Frank et al., 1999) . These cell lines have been in use for up to 40 years, and several CCA and derivative trophoblast hybrid cell lines exist including JAR, JEG-3, BeWo and AC1M. JAR and JEG-3 lines are widely used to study molecular mechanisms underlying proliferation and invasive potential, while BeWo and AC1M-32 and -88 are commonly used to study processes underlying syncytialization, and adhesion and migration, respectively ( Fig. 1 ; Hannan et al., 2010) .
Non-tumour-derived placental cell lines have also been produced from primary placental tissue and cells using a range of transformation methods, including constitutive expression of telomerase (SWAN-71) (Aplin et al., 2006) , SV-40 large T antigen (HTR8/SVneo) (Graham et al., 1993) and retroviral vector-mediated processes (TEV1) (Feng et al., 2005) . The SWAN-71 cells closely resemble EVTs in the expression of immunological antigens and growth factors, and the ability to invade matrigel (Aplin et al., 2006) . The transformed HTR-8/SVneo cell line, derived from the CTB-like HTR-8 cells, resembles EVTs when grown on matrigel (Graham et al., 1993) . The TEV-1 cell line resembles EVTs in the expression of immunological antigens and phenotypic characteristics (Feng et al., 2005) . Unlike the immortalized CCA cell lines, which have been cultured beyond 200 passages, some of the newer model lines show a lower proliferative capacity in culture, ranging from 10 [untransformed EVT-like HTR-8, SWAN-71] to over 100 passages .
In light of recent attempts to characterize genome-wide gene expression differences between trophoblast models (Burleigh et al., 2007) and the unequivocal role of epigenetic variation in mediating changes in gene expression in cell function and development, including placental development and trophoblast function in animal and cell culture systems (Li et al., 1992; Vlahovic et al., 1999; Arima et al., 2006; Rahnama et al., 2006; Serman et al., 2007) , we aimed to profile genome-wide DNA methylation patterns in a wide range of trophoblast models with differing origins and functional capacities. primary CCA tumour material, with (BeWo, JEG-3) or without (JAR) extensive repeated passaging (over several years) through hamster cheek pouches and cell fusion with primary placental trophoblasts (AC1M32). HTR8/SVneo and TEV-1 were derived from first trimester placental villous explants via transformation with Simian Virus-40 large T antigen (SV40Tag) or Human papilloma virus (HPV)-16 E6/E7 proteins, whereas SWAN-71 was derived by immortalization of purified first trimester trophoblasts (CTB) with human telomerase reverse transcriptase (hTERT). (B) Features and utility of specific trophoblast cell line models. hCG, human chorionic gonadotrophin; HLAG, human leucocyte antigen G.
Seven commonly used placental cell lines, TEV-1, HTR8/SVneo, SWAN-71, AC1M32, BeWo, JAR and JEG-3, were examined along with purified first trimester villous cytotrophoblasts (vCTBs) and EVTs. Furthermore, we directly compared our methylation data to previously generated gene expression data in order to highlight the wide-ranging functional consequences associated with methylation variation between different trophoblast populations.
Materials and Methods

Purified primary trophoblast populations
Trophoblast cells were isolated as previously described (Tapia et al., 2008) and purity of preparations determined using antibodies to the trophoblastspecific cytokeratin-7 (CK-7, 1:100 dilution, clone OV-TL 12/30, DakoCytomation, Glostrup, Denmark) or human leucocyte antigen G (HLAG) as previously described (Novakovic et al., 2009) . Only cell preparations in which 95% of the cells were positive for CK7 were used for subsequent experiments. In this study a combination of two independent villous CTB populations were pooled to produce one sample (863/ 864_vCTB). In addition, HLAG+ and HLAG2 trophoblast cell populations were isolated from a further clinical sample. Freshly isolated trophoblast cells were stained with epidermal growth factor receptor (EGFR) and HLAG antibodies and the EGFR -HLAG+ (F58_EVTs) or EGFR+HLAG2 (F58_vCTB) isolated by preparative fluorescenceactivated cell sorter to .99% purity. These correspond to EVT and vCTB trophoblast populations, respectively (Apps et al., 2008) . Ethical approval for the use of these tissues was obtained from the Local Research Ethics Committee.
Trophoblast-derived cell lines
JEG-3 [HTB-36; (Kohler and Bridson, 1971) ] and JAR cells [HTB-144; (Pattillo et al., 1971) ] were maintained in RPMI-1640:10% fetal calf serum (FCS), BeWO [CCL-98; (Pattillo and Gey, 1968) ] in Hams F12:10% FCS and AC1M32 (Drexler et al., 2001) in RPMI-1640:10% CS-FCS for two to three passages following thawing. Placenta-derived cell lines HTR-8/SVneo (Graham et al., 1993) , SWAN-71 (StraszewskiChavez et al., 2009) and TEV-1 (Feng et al., 2005) were obtained from Drs C. Graham (Queen's University, ON, Canada), G. Mor (Yale University, CT, USA) and H. Feng (University of Hong Kong, HK, China), respectively. These were cultured in RPMI-1640:5% FCS (HTR-8/SVneo), Hams F12/Dulbecco's modified Eagle's medium (DMEM):5% FCS:75 mM HEPES (TEV-1) or DMEM:10% FCS (SWAN-71) on plastic, fibronectin or laminin (Becton Dickinson). All cells were cultured at 378C in 5% CO 2 to 80% confluence prior to harvesting for DNA extraction.
DNA methylation analysis
DNA samples were processed using the Methyl Easy TM bisulphite modification kit Human Genetic Signatures, Sydney, Australia), according to the manufacturer's instructions. This process results in selective conversion of unmethylated cytosine nucleotides to uracil, thereby introducing a basechange in genomic DNA analogous to that seen with a single nucleotide polymorphism. This is detectable using appropriate bead-array technology with a single bead detecting either methylated or unmethylated sequences. Infinium arrays were hybridized and scanned as per manufacturer's instructions at Service XS (Leiden, The Netherlands). The arrays were background normalized in BeadStudio (Illumina, San Diego, CA, USA). Individual probe b-values (range 0 -1) were calculated in BeadStudio and are approximate representations of the absolute methylation percentage of specific CpG sites within the sample population. The values were derived by comparing the ratio of intensities between the methylated and unmethylated alleles using the following formula:
where Signal B is the array intensity value for the methylated allele and Signal A is the non-methylated allele. Any probe within a sample with a detection P-value of 0.05 or greater was excluded from further analysis and recorded as an 'NA' (not analysable) for that particular sample. Data analysis was carried out using the statistical programming language R with Bioconductor packages (Gentleman et al., 2004) . Heatmaps were generated using R language package gplots (cran.r-project.org/web/ packages/gplots/gplots.pdf). Locus-specific DNA methylation analysis was performed using the Sequenom EpiTYPER MaldiTOF technology as previously described . PCR primers are listed in Supplementary data, Table S1 .
Gene ontology and pathway analysis
Our approach involved an initial interrogation of data sets with the Ingenuity Pathways Analysis (IPA) application (Ingenuityw Systems, Redwood City, CA, USA; www.ingenuity.com), followed by functional annotation using the Database for Annotation, Visualization and Integrated Discovery (DAVID, http://david.abcc.ncifcrf.gov/home.jsp; Dennis et al., 2003; Huang da et al., 2007) . The IPA functional analysis identified molecular and cellular functions and disease-associated genes most significantly enriched in each of the data sets. The DAVID Ontology tool was used to determine the enrichment of individual gene ontology (GO) terms in each data set. Only 'Biological process' and 'Molecular function' GO terms, which showed significant enrichment (P , 0.05), were reported.
Publicly available gene expression microarray data analysis
Gene expression data were downloaded from Gene Expression Omnibus (Barrett and Edgar, 2006; Sayers et al., 2009) , (Database issue D885-D890). CEL files were downloaded from series GSE9973 (Bilban et al., 2009 ) and GSE2531 (Burleigh et al., 2007) and processed with the bio-conductor package gcrma (Wu and Irizarry). The two expression matrices were merged based on probe ID as both were generated using the same array platform, the Affymetrix Human Genome U133A Array. These comprised three samples of JEG-3, four of BeWo, isolates of primary EVT and five samples of vCTB. Gene expression data were then linked with the methylation data according to gene name. Sample quantiles were produced from the methylation data. The expression values of the genes in each quantile were then plotted as box and whisker plots.
Results and Discussion
Infinium methylation array data accurately reflects endogenous DNA methylation levels
A mixed purified population of CK7+ CTBs (863/864_vCTB), and HLAG+EVT (F58_EVT) and HLAG-vCTB (F58_vCTB) fractions, both obtained from the same original vCTB population were available for methylation profiling in this study, along with seven commonly used trophoblast cell models, with different derivations (Fig. 1) . Validation of results obtained using methylation array analysis was carried out by Sequenom MassArray Epityping. Fourteen genes were tested in different cell lines. Methylation data were plotted where a single CpG site was interrogated by both Infinium and Sequenom platforms.
Supplementary data, Figure S1 shows the correlation between Infinium and Sequenom (which approximates absolute % CpG methylation) for such assays. Pearsons correlation coefficient was 0.78, which is comparable or higher than that previously reported for similar comparisons (Katari et al., 2009; Yuen et al., 2009) , and is equivalent in sensitivity to the corresponding correlation between bisulphite sequencing and Sequenom analysis, further supporting the utility of the Infinium platform.
Trophoblast cell lines differing in origin show variability in methylation levels and distribution
In order to obtain a single measure of overall DNA methylation in different trophoblast populations, we calculated a methylation index (MI) in a similar manner to that previously reported for Infinium methylation data . MI represents the mean b-value of all Infinium probes for which b-values were obtained from all samples. In addition, we examined the distribution of MI relative to CpG density, by dividing probes into those located in annotated CpG islands (CGI-associated) and those that did not fall in these regions (non-CGI-associated) according to Infinium annotation. Interestingly, a gradient of MI was observed in CGI-associated methylation from non-transformed primary trophoblasts (MI ¼ 0.128 for F58_EVTs and MI ¼ 0.144 for F58_ vCTB), to transformed trophoblasts (TEV-1, MI ¼ 0.181 and SWAN-71, MI ¼ 0.186) through to HTRA8/SVneo (MI ¼ 0.276) and CCA-derived trophoblast models (MI ¼ 0.263 for JEG-3 and MI ¼ 0.306 for JAR cells; Table I ). A smaller increase in average methylation relative to primary vCTB is also apparent in all cell models at the non-CGI Infinium probes, most likely due to the higher 'basal' methylation level at these CpG sites in the primary vCTB cells, relative to the CGI-associated sequences (Table I) . Thus, there is a selective increase in CGI-associated DNA methylation with transformation from primary trophoblasts to immortalized cellular models, supporting promoter methylation-induced gene silencing as a mechanism underlying the transformation process.
We also explored the distribution of this methylation in relation to the recently described age-associated differentially methylated regions (aDMRs). These are regions of the genome, recently identified as showing variable methylation over time (Rakyan et al., 2010) , primarily in non-CGI regions. When MI was examined in relation to aDMRs in trophoblasts and derived cell models, a clear enrichment of hypermethylation in these sequences was also apparent, consistent with their localization in primarily non-CGI genomic regions (Supplementary data, Fig. S2 ).
In order to visualize the proportion of Infinium probes showing differential methylation between the three populations of primary cells and the seven placenta cell lines, each was plotted against all others using a scatter plot matrix (Supplementary data, Fig. S3 ). As anticipated primary vCTBs (863/864_vCTB and F58_vCTB) and EVTs (F58_EVT) showed generally highly correlated methylation, while there was a trend towards hypermethylation of specific probe sets in AC1M32, BEWO, JAR, JEG-3 and HTR8/SVneo cell lines relative to primary cell counterparts (Supplementary data, Fig. S3 ). This is in agreement with the increasing MI for these cell lines. Remarkably, very few probes showed a loss of methylation in the cell lines compared with primary trophoblasts, confirming that cellular transformation of trophoblasts in culture is associated with an excess of 'gain of methylation', rather than 'loss of methylation' events at promoter regions.
Epigenetic similarity between trophoblast cells is dependent on cell origin and degree of transformation
The overall relationship of methylation profiles of primary first trimester vCTBs and EVTs was compared with seven trophoblast-derived cell lines using unsupervised hierarchical cluster analysis for Infinium probes showing a coefficient of variation .0.1 (i.e. Most highly variable probes). To put the level of relatedness in context, we included data from primary cord blood mononuclear cells (CBMCs), two solid cancer cell lines (SW48 and MCF-7) and one blood cancer cell line (REH) in the analysis (Fig. 2A) . The resulting relationships were based on their overall correlations (Fig. 2B) . Trophoblast-derived cells were found in two main branches. As expected the four CCA lines clustered together, away from primary CTBs and trophoblastderived cell lines, other than HTRA8/SVneo (Fig. 2A) TEV1 and SWAN-71 were most similar to each other despite their independent generation using differing methodologies and starting material ( Fig. 1) , suggesting a common trophoblast origin. The HTR8/SVneo cell line clustered in the CCA branch but showed an overall methylation profile more similar to unrelated solid tumours (SV48 and MCF-7) than to the tumour-derived trophoblast models ( Fig. 2A) . The clustering of non-transformed CBMCs with primary trophoblast cells and TEV1 and SWAN-71 in a separate branch from all other cells highlights the level of methylation changes associated with cancer-associated transformation and/or long-term cell culturing, irrespective of tumour cell type. Conversely, the higher degree of clustering between the four CCA lines and the two solid cancer cell lines, implicates tumour-associated methylation as a driver of this group's relatedness. However, the HTR8/SVneo data suggest that the level of DNA methylation change associated with some non-tumourigenic cell models may be more extreme than in other lines.
We also examined the relationship between the CCA-derived lines and HTR8/SVneo further and showed a similar number of hypermethylated probes relative to primary trophoblasts in each case. Independent unsupervised clustering of the 1217 most variable probes across these samples (.1.5 SD above the mean) revealed that only a minority of probes are methylated across all CCA lines and very few are commonly methylated between the CCA lines and HTR8/SVneo (Supplementary data, Fig. S4 ). This suggests that a different set of genes were hypermethylated in the transformation process associated with HTR8/SVneo relative to the cancerous CCA lines.
Promoter DNA methylation level is inversely correlated with gene expression in both primary trophoblasts and CCA cell lines
In order to gauge the general effect of DNA methylation on associated gene expression level, Infinium probe methylation level in non-related primary vCTBs and EVTs, and two CCA lines (BeWO and JEG-3), was correlated with publically available expression data. Methylation probes were quantiled according to methylation, with mean b-values of 0.044 (bottom 25% of probes), 0.102 (25-50%), 0.521 (50 -75%) and 0.991 (top 25% of probes), and plotted against either individual sets of expression array data (Supplementary data, Fig. S5 ) or the mean of array data for specific cell populations (Fig. 3) . A general decrease in median expression level was seen for each of JEG-3, BeWo, EVT and vCTBs with increasing methylation level. In addition, there was a marked down-regulation in median gene expression between the second (50%) to third quartiles (75%) associated with a change in mean methylation from 0.102 to 0.521. The inter-quartile range of expression levels was also lower in the upper two quartiles relative to the lower methylation quartiles (Fig. 3) , reflecting the variable expression of genes with low promoter methylation, and general silencing of genes with high promoter methylation levels. While intermediate levels of DNA methylation are not always associated with lower basal gene expression levels, they can play a major role in regulating the capacity for gene expression changes in response to stimuli. Therefore our 'map' of promoter methylation may inform future studies that measure the effects of exogenous stimuli on trophoblast cell function, by explaining variations in gene expression in response to treatment. For example, partially methylated genes may be less likely to respond to a stimulus relative to genes with a fully unmethylated promoter region.
Infinium probes hypermethylated in placental cell lines
GO analysis was performed to identify genes and pathways undergoing epigenetic silencing in placental cell lines of different origins. Probes with a b-value of .0.6 in each cell line were deemed to be 'hypermethylated' relative to CTB cells, provided the CTB b-value was ,0.2 (i.e. ≥0.4 b-value increase). These stringent cut-offs were chosen to select methylation differences that are most likely to be biologically relevant (i.e. result in differential gene expression). The number of probes showing hypermethylation in each cell line is shown in Supplementary data, Table S2 . CCA lines had between 1467 (AC1M32) and 2561 (JAR) probes showing hypermethylation compared with primary CTBs, representing between 6 and 11% of all Infinium probes available for analysis. A large number of hypermethylated probes were also observed for |HTR8/SVneo (1509). Far fewer hypermethylated probes were apparent in respectively) . Interestingly, while 1012 probes (covering 749 genes; many genes have more than a single probe on the array) showed consistent hypermethylation across all CCA lines, only 347 (297 genes) were commonly methylated in HTR8/SVneo and CCA lines (Supplementary data, Fig. S6 ). Furthermore, only 33 probes were hypermethylated across all seven trophoblast models (Supplementary data, Table S2 ). A summary of the top Functions from Ingenuity Pathways and DAVID GO analysis is shown in Supplementary data, Table S3 and Supplementary data, Fig. S7 , respectively. The results of this analysis reflect the similarity between probes hypermethylated in CCA lines.
The top Ingenuity Molecular and Cellular functions consistently hypermethylated in all CCAs and the HTR8/SVneo cell line were 'cancer', 'cell movement', 'cell development' and 'cell growth and proliferation', reflecting the highly proliferative nature of these cell lines, and the silencing of many tumour-suppressor genes by promoter methylation (Supplementary data, Table S3 ). Similar genes are also selectively hypermethylated in CCA relative to SWAN-71 and TEV1 cells (230 cancer-associated genes). Conversely, 29 cancer-associated genes are commonly hypermethylated in SWAN-71 and TEV1 relative to CCAs, including the tumour-suppressor E-cadherin, encoded by CDH1 (for which 4/7 probes show at least Db . 0.2), which was also unmethylated in primary CTBs. E-cadherin silencing is thought to increase proliferation, invasion, and/or metastasis in a variety of different human tumours (van Roy and Berx, 2008; Berx and van Roy, 2009 ).
Placenta-specific tumour-suppressor gene methylation is not always present in trophoblast cell lines IPA recognized 264 Cancer-associated genes (out of a total 643 genes in the IPA list), showing hypermethylation in all CCA lines and hypomethylation in CTBs (b , 0.2), suggesting that the silencing of these genes is an aberration associated with CCA development. However, recent studies have identified several cancer-associated genes that Figure 3 Relationship between DNA methylation and gene expression in trophoblast cell populations. Illumina BeadChip methylation data for JEG-3, BeWo, purified HLAG+ EVTs (F58_EVT) and purified vCTB (863/4 vCTB) was divided into quantiles according to probe numbers (i.e. equal numbers of Infinium probes in each group). Mean methylation b-value for each group is shown in parentheses. These were then plotted (x-axis) against the corresponding gene expression values obtained from publicly available vCTB and EVT data (intensities; y-axis) in order to display the overall effect of increasing methylation on gene expression. This analysis clearly shows a decreasing median gene expression with increasing methylation, highlighting the functional relevance of DNA methylation in these cell lines.
are selectively methylated in human placental tissue and primary trophoblast cells (Chiu et al., 2007; Novakovic et al., 2008) . The role of this methylation in specifying specific aspects of placental function remains unclear.
We were interested in examining the methylation of several tumour-associated genes previously demonstrated to show increasing methylation in placental cell lines as a first step in understanding their potential involvement in specific aspects of trophoblast functioning.
Differences in methylation of such genes were predicted to impact on functional characteristics of host cell lines. Table II lists the methylation levels of several published tumour-suppressor genes in vCTBs and the seven cell lines. Interestingly, several genes (APC, CD44, RASSF1 and KIAA0101), all previously shown to be monoallelically methylated in the placenta, were hypomethylated in all non-CCA-derived trophoblast cell lines, and in the case of KIAA0101, also in the CCA lines. Given the roles of these genes as inhibitors of proliferation, migration and tumourogenesis, it is unclear why transformation should lead to a decrease in methylation levels at these sites. Despite these aberrations, the general trend in CCA is an increase in methylation of this class of genes, supporting a role for such methylation in specifying some of the 'tumour-like properties' of trophoblast cells (Ferretti et al., 2007) .
Trophoblast cell lines show variation in epigenetic signatures at immune-related genes
Due to the differential expression of HLA markers in different placental cell lines, we sought to determine if these differences can be explained by DNA methylation (Supplementary data, Table S4 and Supplementary data, Fig. S8A ). CTB cells show a range of methylation levels for the different HLA genes (0.04 for HLA-G to 0.64 for HLA-DRA), however, they do not express any of these HLA markers. Likewise for placental cell lines, DNA methylation level did not correspond with HLA expression patterns. One possible exception is the CCA cell line JEG-3, which showed high methylation for HLA markers that are not expressed in this cell line-HLA-A (0.68), HLA-B (0.8), HLA-DRA (0.76) and HLA-F (0.91), and lower methylation for HLA-C (0.28), HLA-E (0.54) and HLA-G (0.5), all of which are expressed in this cell line (r 2 ¼ 0.75). These data support the idea that a lower DNA methylation is associated with a potential for gene expression, whereas a high level of methylation is not generally compatible with either basal or inducible gene expression. However, it is clear that the lower methylation of the specific sites in cells such as primary vCTB is not sufficient in itself to drive expression of genes such as HLA-C. Further analysis of genes involved in regulation of immune response (GO term: 0050776), revealed 40 immune regulators with differential methylation in different cell lines (Supplementary data, Fig. S8B ). Specific genes showing differential methylation between CCA and primary vCTBs in at least two probes include SYK (seven probes), TNF, CD40, STAT5B, CR1, IL15, TLR2 and RBP4. The consequences of such differential methylation on immune regulatory properties and antigen expression will require further investigation.
A role for altered DNA methylation in regulating hCG?
Human chorionic gonadotrophin (hCG) is a hormone produced by the syncitiotrophoblast layer and secreted into the maternal compartment. It is also expressed more highly in EVTs than villous CTBs. CCAs (such as those used to generate CCA cell models) are epithelial tumours which produce hCG (Seckl et al., 2010) . In this study, we found that the hCG a-subunit gene promoter shows approximately equal methylation in all trophoblast cell lines tested. However, that of the b-subunit gene differed between cell populations. CGB5 and 8, which make up 60 -80% of total hCG-b transcripts (Uuskula et al., 2010) , show low methylation in primary vCTBs (mean b ¼ 0.28) and almost no methylation in EVTs (mean b ¼ 0.054), consistent with the elevated expression of hCG in EVTs relative to CTBs (Handschuh et al., 2007) . Increasingly higher methylation of these genes was seen in CCA lines ( Fig. S8F ). Our analysis revealed differences between primary cells and CCA lines across several gene families and genes involved in specific pathways. This suggests that the large-scale differences in DNA methylation between vCTBs and CCA lines are not limited to a specific group of genes, but affect genes involved in many different aspects of trophoblast cell function.
Concluding comments
In this study, we have revealed the wide-ranging and functionally relevant differences in DNA methylation profile that exist between primary human trophoblasts and derived cell models. At present it is unclear which of these differences are due to the variable starting material (e.g. tumour versus non-tumour), transformation process, or cell culturing factors (media, cell culturing), or a combination of all three factors. Irrespective of this, the extent of epigenetic differences and the proven role of epigenetic modification in regulation of gene expression and therefore cell morphology and function are anticipated to impart profound functional differences on the cell models relative to their primary trophoblast counterparts. The classes of genes shown to be selectively altered need to be considered in the interpretation of functional data obtained in such systems, supporting replication of findings in primary cell populations wherever possible. Conversely, further analysis of differentially methylated pathways identified in this study in cell models with different functional capacities, offers tremendous opportunities to identify candidate genes involved in specific aspects of trophoblast function and capacity. Finally, as changes in DNA methylation alone cannot fully explain all of the known expression differences between cell models, there is a need for investigation of other epigenetic processes in trophoblast cells.
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Authors' roles B.N., R.S., U.M., J.M.C., A.S. and A.M. study design, conception, final revision and final approval; L.G., N.W. data acquisition, analysis, interpretation and final approval.
